The biological consequences of altered MHC class I expression in tumours

Journal of Biological Regulators and Homeostatic Agents

Volumn 13, Issue 2, 1999, Pages 90-96

  Algarra, I ^a   Gaforio, J J ^a   Cabrera, T ^a   Collado, A ^a   Garrido, F ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

HLA; Metastasis; Phenotypes; Tumours

Indexed keywords

BETA 2 MICROGLOBULIN; HLA ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA;

ALLELE; ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; BURKITT LYMPHOMA; CANCER INVASION; CHROMOSOME 6; CLASSIFICATION; COLON CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; GENE LOCUS; GENE LOSS; GENE MUTATION; GENE REPRESSION; HETEROZYGOSITY LOSS; HUMAN; LARYNX CARCINOMA; MELANOMA CELL; METASTASIS; ONCOGENE MYC; PANCREAS CANCER; PHENOTYPE; PROSTATE CANCER; TUMOR CELL LINE; UTERINE CERVIX CANCER;

EID: 0033303334     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides
2. Generation, intracellular transport and loading of peptides associated with MHC class I molecules
3. Inhibitory receptor for HLA class I molecules on cytolytic T lymphocytes. Functional relevance and implications for anti-tumor immune responses
4. HLA Class I antigens in human tumors
5. Antigenic tumor cell variants obtained with mutagens
6. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1
7. A recombinant vaccinia virus encoding human paillomavirus types 16 and 18, E6 and F7 proteins as immunotherapy for cervical cancer
8. MHC antigens and malignancy
9. Further evidence for derepression of H-2 and la like specificities of foreign haplotypes in mouse tumour cell lines
10. Variation in MHC antigenic profiles of tumor cells and its biological effects
11. HLA and cancer: From research to clinical impact
12. Heterogeneity of MHC-class I antigens in clones of methylcholantrene induced tumors. Implications for local growth and metastasis
13. Generation and control of metastasis in experimental tumor systems; Inhibition of experimental metastases by a tilorone analogue
14. Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene
15. How to recognize a foreign submarine
16. Receptors for HLA class I molecules in human natural killer cells
17. Inhibitory MHC class I receptors on NK cells and T cells
18. In search of the ″missing self': MHC molecules and NK recognition
19. Implications for immunosurveillance of altered class I phenotypes in human tumours
20. The detailed distribution of HLA ABC antigens in normal human organs
21. HLA class I and II expression in rhabdomyosarcomas
22. MHC class I antigens on gastric carcinomas and autologous mucosa
23. Natural history of HLA expression during tumour development
24. Class I and II HLA antigen distribution in normal mucosa, adenoma and colon carcinoma: Relation with malignancy and invasiveness
25. HLA and cancer
26. Mutations of the β2-microbobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides
27. HLA and cancer
28. Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line
29. Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors
30. In vivo and in vitro generation of a new altered HLA phenotype in melanoma tumor cell variants expressing a single HLA class I allele
31. Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection
32. Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas
33. A weakly tumorigenic phenotype with high MHC class I expression is associated with high metastatic potential after surgical removal of the primary murine fibrosarcoma
34. Altered MHC class I antigens in tumors